Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,173,327,597
+$560,064,131 QoQ
Shares Held
20,558,447
-3.1% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#12
of 4,145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. ABBV ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,173,327,597 | 20,558,447 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $4,613,263,466 | 21,211,382 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $4,965,984,061 | 21,733,923 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,104,583,395 | 22,046,227 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,086,122,477 | 22,013,374 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,612,356,512 | 22,013,920 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,878,236,034 | 21,824,626 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,855,793,246 | 19,524,981 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,479,127,457 | 20,284,092 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,687,572,343 | 20,250,260 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,244,469,429 | 20,936,113 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,269,821,746 | 21,936,279 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,889,269,758 | 21,444,888 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,541,998,886 | 22,225,004 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,548,377,843 | 21,956,425 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,933,132,168 | 21,854,796 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,396,283,789 | 22,174,744 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,668,737,507 | 22,631,161 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,089,493,017 | 22,817,526 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,461,131,714 | 22,815,720 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,551,818,310 | 22,654,637 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,567,790,156 | 23,727,501 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,562,329,272 | 23,913,479 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,133,971,984 | 24,363,192 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,371,354,889 | 24,153,136 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,550,042,044 | 20,344,429 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||